Study: Treating Anemia Could Save Half of Maternal Deaths

A medical breakthrough is rewriting what the world knows about saving mothers during childbirth, and the solution might be simpler than anyone expected.

The WOMAN-2 study, tracking 15,000 women across Nigeria, Pakistan, Zambia, and Tanzania, discovered that anemia is the hidden killer behind many maternal deaths previously blamed on excessive bleeding. Researchers found that women with low hemoglobin levels can go into shock and organ failure after losing even moderate amounts of blood during delivery.

The findings flip decades of medical thinking on its head. For years, postpartum hemorrhage has topped the list of maternal death causes, leading doctors to focus primarily on stopping severe bleeding after birth.

But this research shows the real villain often strikes earlier. Women carrying anemia into pregnancy face dramatically higher risks when any bleeding occurs because their bodies simply don't have enough healthy blood to lose.

Nigeria shoulders a quarter of the world's maternal deaths, with 1,047 mothers dying per 100,000 births according to WHO estimates. The study suggests many of these tragedies could be prevented with better anemia screening and treatment before and during pregnancy.

The discovery also revealed a troubling treatment gap. Current WHO guidelines for managing postpartum hemorrhage, published in 2023, didn't incorporate these findings because the research wasn't yet complete.

This means doctors worldwide may be missing critical warning signs. The study showed that women with severe anemia were twice as likely to be diagnosed with dangerous hemorrhaging despite losing less than 500ml of blood, suggesting current diagnostic methods don't account for their unique vulnerability.

The Ripple Effect

The researchers are calling for immediate changes that could save thousands of lives annually. They recommend screening all pregnant women for anemia, ensuring hemoglobin levels are known during delivery, and making tranexamic acid, a bleeding-reducing medication, widely available in delivery rooms.

What makes this particularly hopeful is how achievable these solutions are. Unlike building new hospitals or training thousands of specialists, testing hemoglobin levels and treating anemia uses existing, affordable technology that clinics already possess.

The study also warns against a common medical reflex that could harm anemic mothers. When vital signs change, doctors often administer IV fluids to combat suspected hemorrhaging, but in anemic women without heavy bleeding, this can cause dangerous fluid overload and breathing problems.

Armed with this knowledge, health systems across sub-Saharan Africa and South Asia now have a clear roadmap for cutting maternal deaths without waiting for massive infrastructure investments.

For the mothers of Nigeria and beyond, understanding that anemia screening could mean the difference between life and death transforms pregnancy care from reactive crisis management into proactive protection.